Vanguard Fiduciary Trust
ATNM icon

Vanguard Fiduciary Trust’s Actinium Pharmaceuticals ATNM Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Buy
161,526
+1,261
+0.8% +$1.46K ﹤0.01% 3642
2026
Q1 		$159K Buy
+160,265
New +$191K ﹤0.01% 3580

Other funds holding ATNM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return

Vanguard Fiduciary Trust's ATNM Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Actinium Pharmaceuticals (ATNM) stake by 0.79% in Q2 2026, buying an estimated $1.46K and bringing the position to 161,526 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #3642.

Vanguard Fiduciary Trust first reported a position in ATNM in Q1 2026 and has held it in 2 quarters since. The position peaked at $159K in Q1 2026. 46 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • Vanguard Fiduciary Trust held 161,526 shares of Actinium Pharmaceuticals worth $158K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 1,261 Actinium Pharmaceuticals shares in Q2 2026, an estimated $1.46K.
  • Actinium Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3642 holding.
  • Vanguard Fiduciary Trust first reported a position in Actinium Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Actinium Pharmaceuticals position peaked at $159K in Q1 2026.
  • 46 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.